Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
about
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patternsEconomics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic ReviewRational prescribing in primary care (RaPP): a cluster randomized trial of a tailored interventionMeta-regression analyses to explain statistical heterogeneity in a systematic review of strategies for guideline implementation in primary health care.Stakeholder experiences with general practice pharmacist services: a qualitative studyInterventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007Cost-effectiveness of Anticipatory and Preventive multidisciplinary Team Care for complex patients: evidence from a randomized controlled trial.The potency of team-based care interventions for hypertension: a meta-analysis.Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative interventionPhysician and pharmacist collaboration to improve blood pressure controlClinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.Sustained blood pressure control following discontinuation of a pharmacist intervention.The economics of medicines optimization: policy developments, remaining challenges and research priorities.An evaluation of a clinical pharmacy-directed intervention on blood pressure control.Multiprofessional interventions to improve patient adherence to cardiovascular medications.Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS).Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart DiseaseEffects of primary care team social networks on quality of care and costs for patients with cardiovascular diseaseThe hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy.The common characteristics and outcomes of multidisciplinary collaboration in primary health care: a systematic literature reviewAliskiren in hypertension: evidence for its potential therapeutic valueCaring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy.The potential role of clinical pharmacy services in patients with cardiovascular diseasesTake Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control.Incremental costs associated with physician and pharmacist collaboration to improve blood pressure controlA cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.Evolution of Clinical Pharmacy in the USA and Future Directions for Patient CareStrategies for establishing policy, environmental, and systems-level interventions for managing high blood pressure and high cholesterol in health care settings: a qualitative case study.Physician-pharmacist co-management and 24-hour blood pressure control.The 2007 Canadian Hypertension Education Program recommendations: the scientific summary - an annual update.A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertensionElectronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation frameworkImplementing effective hypertension quality improvement strategies: barriers and potential solutions.Patient self-management support: novel strategies in hypertension and heart disease.A collaborative cardiologist-pharmacist care model to improve hypertension management in patients with or at high risk for cardiovascular disease.Hospital pharmacy practice in Saudi Arabia: Drug monitoring and patient education in the Riyadh region.Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.Use of specialty care versus standard retail pharmacies for treatment of hepatitis C.Quality patient care and pharmacists' role in its continuity--a systematic review.
P2860
Q24234308-20828E14-652E-4060-A6E1-C51AFAD3B6D4Q28083249-8222E2A1-C9C8-459B-B5BD-FF4C165909CAQ28469006-E3C7C1FC-A3E9-4BBF-86AF-07D3703F7806Q30317003-911C8560-9ED8-4F34-922E-899B5C2802A5Q30544862-08D8589F-104E-4E09-B245-CC5EFA68C3BDQ33327179-83B057F6-B81A-471B-B1B9-63389DED163BQ33601867-9A3A1E01-AC2E-4AE2-A30C-1FE2045DB336Q33899620-C945B083-3C33-4CBD-807C-EA8F969B0264Q33899634-E75BDE28-EC5B-4FDF-82FC-13803D2BA63FQ33899657-2CD420E1-247C-48B7-B7E4-E0FD9877984CQ33967473-6D1332E2-44E2-4BF3-94CF-6CE3D532AAF1Q34019198-1B868C8F-E876-4E80-BA4C-FEFEBA6D9853Q34132415-76463DA5-C63C-455D-954F-58DF0320902EQ34145117-CBB1FFD3-F918-4266-8384-79821E3F55BCQ34233105-FF46FD3C-61D8-456E-BF67-5612532E75F3Q34297241-D07EFAFB-4F19-4C73-8824-478CCFA16574Q34372817-D022C550-F4DD-400F-97E5-EBC3A0516B1DQ34730092-B32066E5-09D9-445A-A3A6-D3F18D02FDFEQ35205990-5B304AA4-2068-441E-98CC-53FBBB7C7810Q35671360-438461FB-E4E8-40EE-85C3-3A0C89F35707Q35817132-F4C00C0A-A1A8-46E3-A33F-25E22C296075Q35876368-DDCEF55F-D8E7-4A1B-99DE-39CE0D02C5C1Q36070911-B6269474-B6CE-4ADE-B8A0-D1EE42BAE771Q36305124-9B9149A1-8598-4C99-A6AE-8B10EF65C216Q36513234-884B4946-E43A-4437-A4AD-42D9F78E929FQ36533970-2EDBF1C3-4352-4C29-8423-3AE1836B13DCQ36755264-CC94B2AE-156C-41FF-84B1-3F80C3F89B4EQ36767799-52ED8041-2A4E-45E5-97FE-A17F0F0BA935Q36790686-EF90CD1C-A285-4A27-8E80-F568169477DAQ36810684-D9B8DCAC-7415-425B-A5DB-43026202D704Q36834042-EA06704E-A884-4C68-8661-A79A821D4868Q37000394-9130B132-A6C2-4BDE-A9AC-B8020C03E3D5Q37103760-3D3A0626-6FA7-4A0F-8E35-DB200A6DBD6DQ37133919-1B2E2091-65EE-4302-A8D2-C1B09B289B0BQ37149469-1C2AA237-222C-418A-9A7D-A330E350E68DQ37233368-736DB786-5C87-43B0-8FC5-A0BA31D99B62Q37300412-F7E225BB-EBEC-485C-B161-5AC37773BF40Q37318113-A1CC6AF1-5F20-4A15-9E7E-9A56210C0D9DQ37385551-C4EADF98-0161-45A2-8EA8-9B4DE711327EQ37428369-0B5C8849-4987-4706-9510-B0F40E15406B
P2860
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
@en
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
@nl
type
label
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
@en
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
@nl
prefLabel
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
@en
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
@nl
P2093
P2860
P1433
P1476
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
@en
P2093
Emmanuel Saltiel
Geneen Graber
Jackson Archi
Jeff E Borenstein
Joel Wallace
Scott R Weingarten
Seonyoung Ryu
Stephen Deutsch
P2860
P304
P356
10.1592/PHCO.23.2.209.32096
P407
P577
2003-02-01T00:00:00Z